JOSE GRIJALVA: Open Payments
NPI 1932690419 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,930 in 34 payments from 4 companies in 2025. Trend: 2023 $391 · 2024 $828 · 2025 $18,930
Speaker / faculty: $15,100Travel & lodging: $2,261Food & beverage: $1,457Education: $111
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 28 | $18,513 |
| Teva Pharmaceuticals USA, Inc. | 2 | $233 |
| Otsuka America Pharmaceutical, Inc. | 3 | $158 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
Products named: NUPLAZID, REXULTI, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
